Our speakers will focus on:

 

Dani Saurymper - After the outstanding returns and significant retail investor inflows into Health and Biotech, where now for these dynamic sectors?

Richard Marwood - Market uncertainty and volatility persists. What are the key issues facing cautious investors and how can advisers help build robust portfolios for these clients?

Nicolas Trindade - With bond yields edging higher in the UK and US, many are anticipating a normalisation of monetary policy in the short to medium term. What does this mean for bond investors and how can a short duration approach help in mitigating key risks?

Chris St John - The UK economic recovery continues to gather pace, presenting opportunities for investors across the market capitalization spectrum. What are the key growth drivers and potential hurdles for UK equity investors to be aware of?

Past performance is not a guide to future performance